OKYO Pharma Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $4,733,246.

Profit Margin

OKYO Pharma Limited (LSE:OKYO.L): Profit margin
2010 0 8.40M
2011 0 -1.00M
2012 0 -3.00M
2013 0 -3.06M
2015 0 -5.57M
2016 0 -570.71K
2018 0 -53.14M
2019 0 -3.75M
2021 0 -2.99M
2022 0 -4.13M

OKYO.L Income Statement (2010 – 2021)

2021 2020 2018 2017 2015 2014 2013 2012 2011 2010
Revenue
Revenue
0000000000
Cost of revenue
0000000000
Gross profit
0000000000
Operating exp.
Research and development
990.54K132.86K2.33M0000000
Selling and marketing
000000001K3K
Total operating expenses
4.73M3.00M3.74M837.50K764.03K1.31M3.11M3.38M1.06M-13.66M
Operating income
-4.73M-3.00M-3.74M-837.50K-764.03K-1.31M-3.11M-3.38M-1.06M13.66M
Other income (expenses), net
0-9.39K-12.12K-52.31M61.11K-4.25M51.85K-178K-54K5.25M
Income before tax
-4.73M-3.01M-3.75M-53.14M-702.91K-5.57M-3.06M-3.56M-1.00M8.40M
Income tax expense
-598.75K-19.10K-12.12K0-132.20K051.85K000
Net income
-4.13M-2.99M-3.75M-53.14M-570.71K-5.57M-3.06M-3.00M-1.00M8.40M
Earnings per share
Basic EPS
-0.00-0.00-0.00-0.14-0.00-0.01-0.01-0.02-0.000.02
Diluted EPS
-0.00-0.00-0.00-0.14-0.00-0.01-0.01-0.02-0.000.02
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source